Last time i recieved a source for the 95% number, it was from the 14 day study that got big pharma emergency approval. And it was based on DIAGNOSIS. Not hospitalization, not death, not transmission.
And, in the extended study (28 days), the differences between the two groups (vaccine and control) all but disappeared.
Keep in mind that diagnosis was positive pcr test + symptom of infection, which doesn't tell you much of anything.
"the absolute risk reduction (ARR), which is the difference between attack rates with and without a vaccine, considers the whole population. ARRs tend to be ignored because they give a much less impressive effect size than RRRs: 1·3% for the AstraZeneca–Oxford, 1·2% for the Moderna–NIH, 1·2% for the J&J, 0·93% for the Gamaleya, and 0·84% for the Pfizer–BioNTech vaccines."
(post is archived)